PREPARATION AND CHARACTERIZATION OF SOLID DISPERSION FAMOTIDINE â€“ MANNITOL BY CO-GRINDING METHOD by Fitriani, Lili et al.
Vol 10, Issue 3, 2017
Online - 2455-3891 
Print - 0974-2441
PREPARATION AND CHARACTERIZATION OF SOLID DISPERSION FAMOTIDINE – MANNITOL 
BY CO-GRINDING METHOD
LILI FITRIANI, SHERLY RAMADHANI, ERIZAL ZAINI*
Department of Pharmaceutics, Faculty of Pharmacy, Andalas University, Padang, West Sumatera 25163, Indonesia. 
Email: erizal.ffua@gmail.com
Received: 10 November 2016, Revised and Accepted: 23 November 2016
ABSTRACT
Objective: This study aims to prepare and characterize solid dispersion of famotidine using mannitol to enhance the solubility and dissolution rate.
Methods: Solid dispersions were prepared by co-grinding method in 9 formulas. The ratio of famotidine and mannitol was varied (1:1, 1:2, 2:1 w/w), 
and each ratio was milled at three different times (30, 60, and 90 minutes). The physical mixture was also prepared as comparison at ratio 1:1 w/w. 
Solid dispersions were characterized by X-ray diffraction analysis, Fourier transform infrared (FTIR) spectroscopy, differential scanning calorimetry 
(DSC) analysis, scanning electron microscopy (SEM), particle size analysis, solubility, and dissolution rate study. The assay of famotidine was done 
using a UV spectrophotometer.
Results: The highest solubility of famotidine in solid dispersion was obtained in F2 (ratio 1:2 and grinding time 30 minutes). The solubility of intact 
famotidine, physical mixture, and solid dispersion F2 was 1.630±0.027, 2.757±0.096, and 3.272±0.076 mg/ml, respectively. X-ray diffractogram of 
solid dispersion F2 showed a decrease in the peak intensity of famotidine. Thermogram of DSC showed a decrease of famotidine melting point for both 
physical mixture and solid dispersion. Photomicrograph of SEM indicated the changes in morphology solid dispersion compared to intact substances. 
FTIR analysis showed no chemical interaction between famotidine and mannitol. The particle size analysis showed a reduction in the particle size 
of the solid dispersion. The dissolution result after 60 minutes was 85.029%, 86.166%, 92.057% for intact famotidine, physical mixture, and solid 
dispersion F2, respectively.
Conclusion: Solid dispersion increased solubility and dissolution rate.
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INTRODUCTION
Famotidine is an H2 receptor antagonist, acts similar to cimetidine, 
which inhibits H2 receptor selectively and reversibly [1]. In general, 
famotidine is used for the treatment of gastric ulcers, duodenal ulcers, 
Zollinger-Ellison syndrome, and gastroesophageal reflux disease. 
Compared to others H2 receptor antagonist, famotidine has 7.5 times 
more potent than ranitidine and 20 times than cimetidine [2]. Famotidine 
is better than cimetidine since it does not have antiandrogenic effect 
which causes sexual dysfunction (impotence) and gynecomastia [1].
Famotidine is classified into Class IV based on Biopharmaceutics 
Classification System, which has low solubility and low permeability [3]. 
The availability of drugs given orally in the blood such as famotidine 
depends mainly on solubility in the gastrointestinal fluids and drugs 
across the permeability of membrane cell in gastrointestinal tract [4]. 
Drugs which have low solubility mostly show a low gastrointestinal 
absorption, which causes low oral bioavailability [5].
A number of methods have been developed to overcome 
the problem of solubility and dissolution rate including salt 
formation [6], micronization and microspheres [7,8], complexation 
with β-cyclodextrin [9], micellization [10], and formation solid 
dispersion [11,12]. Solid dispersion is defined as the dispersion of 
the active ingredient in an inert carrier or matrix in the solid state. 
In the manufacture of solid dispersion system, it is very important to 
understand the physicochemical properties of the drug and a suitable 
carrier to increase the dissolution rate of drugs [13]. Various techniques 
can be done to prepare solid dispersion; one of them is co-grinding [14].
Co-grinding can enhance the solubility by reducing particle size 
reduction and change crystalline becomes amorphous form or 
decreases the crystallinity degree [15]. Compared to other techniques 
used to increase solubility, the co-grinding technique is a simple 
process and friendly for environmental since it does not require organic 
solvents [16]. Mannitol is one carrier that can be used to prepare solid 
dispersion. Mannitol belongs to sugar alcohol group which has high 
water solubility. Moreover, mannitol has a lower toxicity that could be 
used as a carrier in the manufacture of solid dispersion [17].
In this study, solid dispersion of famotidine with mannitol was prepared 
and characterized with the aim to increase the solubility and dissolution 
rate of famotidine. Characterization of solid dispersions was done by 
scanning electron microcopy (SEM), X-ray diffraction analysis, Fourier 




Famotidine (PT SanbeFarma, Indonesia), mannitol (Merck, Germany), 
methanol (Merck, Germany), KH2PO4 (Bratachem, Indonesia), liquid 
paraffin (Bratachem, Indonesia), and distilled water. All materials were 
used as received.
Preparation of solid dispersion
Famotidine and mannitol were mixed at a ratio of 1:1, 1:2, and 
2:1 (w/w). The mixture was ground in Planetary Ball Mill (Fritsch, 
Pulverisette 7, Germany) at 500 rpm for 30, 60, and 90 minutes for each 
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ratio. The co-grinding powder was kept in desiccator. The formula of 
solid dispersion can be seen in Table 1.
Preparation of physical mixture
Physical mixture of famotidine mannitol was prepared at ratio of 
1:1 (w/w). The mixture was mixed homogeneously, stored in a sealed 
container and kept in a desiccator.
Solubility test
An excess amount of famotidine in the samples was added to 100 mL 
of distilled water. Solubility test was conducted for 72 hrs in an 
orbital shaker at room temperature. Samples were analyzed using 
UV spectrophotometer (Shimadzu UV-1700, Japan) at λmax famotidine 
283 nm.
Powder X-ray diffraction analysis
Analysis of X-ray powder diffraction was performed using an X-ray 
diffractometer (PAN analytical PW 30/40 X-ray diffractometer, the 
Netherlands). Samples were placed on the sample holder and leveled 
to prevent particle orientation during sample preparation. The analysis 
was performed at 2θ in a range 5-40°. Measurement condition was as 
follow: Target metals Cu, Kα filter, voltage 45 kV, and current 40 mA. 
The measurement was conducted for intact famotidine, intact mannitol, 
physical mixture, and solid dispersion F2.
SEM analysis
The sample powder was placed on an aluminum sample holder, and 
the voltage was set at 10 kV and current 12 mA. Samples were then 
observed on various magnifications using SEM (HITACHI type S-3400N, 
Japan). SEM was done for intact famotidine, intact mannitol, physical 
mixture, and solid dispersion F2.
DSC analysis
The thermal properties of intact famotidine, intact mannitol, physical 
mixture, and solid dispersion of F2 were determined using a thermal 
analyzer (Mettler Toledo FP90, Switzerland), which has been calibrated 
with Indium temperature. Each sample in a small amount was placed 
on an aluminum pan, and the instrument temperature was set in a 
range from 50°C to 250°C at 10°C per minute of heating rate.
Infrared spectroscopy analysis
The samples were measured with a PerkinElmer FTIR 
Spectrophotometer, where the samples absorption spectra were 
recorded at wave number 4000-600/cm. FTIR analysis was done 
for intact famotidine, intact mannitol, physical mixture, and solid 
dispersion F2.
Particle size analysis
Particle size analysis was conducted using an optical microscope, and 
about 500 particles were counted to obtain a good estimation of the 
particle size distribution. Particle size analysis was done for intact 
famotidine, physical mixture, and solid dispersion F2.
Dissolution test
Dissolution test of intact famotidine, physical mixture, and solid 
dispersion F2 was done in a dissolution tester (SR8 Plus Dissolution 
Test Station Hanson Virtual Instrument, USA) type I. The medium for 
dissolution test was 900 ml phosphate buffer pH 4.5. The dissolution 
tester was set at temperature 37°C±0.5°C and the speed was 50 rpm. 
Samples were pipetted at 5, 10, 15, 30, 45, and 60 minutes. The 




The solubility test was conducted by measuring the amount of 
famotidine dissolved in distilled water using spectrophotometer. The 
result of solubility test can be seen in Table 2. According to these 
results, the solubility of solid dispersion increased compared to intact 
famotidine and physical mixture. The improvement of solubility 
occurred due to the grinding process by co-grinding methods that 
reduce the particle size and increase surface (result of particle size is 
shown later). Moreover, improvement solubility of solid dispersion was 
also contributed by a decrease of crystallinity degree (result of powder 
X-ray diffraction is described later).
Powder X-ray diffraction
The diffractogram of intact famotidine, intact mannitol, physical 
mixture, and solid dispersion F2 can be seen in Fig. 1. The results of 
X-ray diffraction analysis showed the crystallinity of famotidine was 
characterized by typical and sharp peaks at 2ϴ:11.386°, 19.998°, 
and 22.140°; while peaks of mannitol were at 18.555°, 20.825°, and 
23.215°as shown in Table 3. Solid dispersion F2 showed the crystalline 
form which was a superimposition of famotidine and mannitol 
diffraction peaks, yet the interference peak intensity was decreased. 
The peak intensity of physical mixture also decreased, but not as 
greater as the solid dispersion F2. A decrease in the peak intensity of 
the interference showed the changes in the degree of crystallinity of 
famotidine [18].
DSC analysis
The thermal properties of intact famotidine, intact mannitol, physical 
mixture, and solid dispersion of F2 can be seen in thermogram 
Fig. 2. Famotidine showed a sharp peak and the melting point was 
164.18°C, and mannitol also depicted a sharp peak with the melting 
point at 166.79°C. The physical mixture showed a decrease of melting 
point, which corresponded to famotidine melting point at 154.65°C. 
Meanwhile, solid dispersion of F2 showed two endothermic peaks 
at 150.59°C and 160.29°C, where these two peaks were represented 
famotidine and mannitol, consecutively.
SEM analysis
The photomicrograph SEM of intact famotidine, intact mannitol, 
physical mixture, and solid dispersion F2 is shown in Fig. 3. The 
morphology of intact famotidine looked like a rod crystalline form, 
while the mannitol showed an irregular shaped in larger size. The 
physical mixture showed that famotidine stick on mannitol. In contrary, 
the solid dispersion depicted the smaller particles, which is due to 
mechanical energy from the grinding process that causes changes in 
Table 1: Formulation of solid dispersion famotidine - mannitol
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spectrum of solid dispersion showed a combination of functional 
groups of famotidine and mannitol. The IR spectrum did not show 
any new functional groups formed, which indicated a simply physical 
interaction between famotidine and mannitol [14].
Particle size distribution analysis
The particle size distribution was done using an optic lab microscope, 
and the result is shown in Fig. 5. In general, the particle size of particles 
was in range of 0-300 µm. The most particle size of intact famotidine 
and physical mixture was in range 50.1-100 µm, while the solid 
dispersion was in range 0-50 µm. This indicated that the particle size 
distribution of solid dispersion F2 was smaller than intact famotidine 
and physical mixture [16].
Dissolution test
The dissolution test result of intact famotidine, a physical mixture, 
and solid dispersion F2 is shown in Fig. 6. The percentage of intact 
famotidine, a physical mixture, and solid dispersion F2 dissolved after 
60 minutes were 85.029%, 86.166%, and 92.057%, respectively. The 
dissolution of intact famotidine, physical mixture, and solid dispersion 
F2 showed significant differences (p<0.05). This indicated that an 
increase on the dissolution rate of famotidine.
DISCUSSION
The highest solubility was solid dispersion of Formula 2 (F2) at ratio of 
famotidine mannitol 1:2 and grinding time 30 minutes. The amount of 
mannitol and grinding time likely influenced the solubility of famotidine. 
Table 3: Peak intensity of intact famotidine, intact mannitol, physical mixture and solid dispersion F2
Position (2θ) Peak intensity
Intact famotidine Intact mannitol Physical mixture 1:1 Solid dispersion 1:2 (F2)
11.386 2736.9 - 2274.4 1559.4
18.555 - 24,222 9516.3 3596.2
19.998 5622.3 - 4492.2 2351.5
20.825 - 6541.7 2229.1 2931.4
22.140 3314 - 2772.3 2054.5
23.215 - 43,741 4374.1 4586.3
Fig. 1: Diffractogram of (a) intact famotidine, (b) intact mannitol, (c) physical mixture, (d) solid dispersion F2
Fig. 2: Thermogram of (A) intact famotidine, (B) intact mannitol, 
(C) physical mixture, and (D) solid dispersion F2
the particle size [19]. This photomicrograph SEM results supported 
the solubility test.
FTIR analysis
The results of FTIR analysis for intact famotidine, intact mannitol, 
physical mixture, and solid dispersion F2 are shown in Fig. 4. The IR 
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Fig. 4: Fourier transform infrared spectrum of (A) intact 
famotidine, (B) intact mannitol, (C) physical mixture, and 
(D) solid dispersion F2
Fig. 5: Particle size distribution of (▲) solid dispersion F2, 
(■) physical mixture, and (♦) intact famotidine
Fig. 6: Dissolution profile of (▲) solid dispersion F2, (■) physical 
mixture, and (♦) intact famotidine
The amount of mannitol affected the solubility due to the polarity of 
mannitol. In addition, mannitol is known as a hygroscopic material 
which tends to absorb moist from the air. Thus, the longer grinding 
time, the more mannitol contact in air and caused a sticky mannitol on 
the planetary ball mill chamber. Therefore, further characterization was 
done only for intact famotidine, intact mannitol, physical mixture, and 
solid dispersion F2.
The decrease of crystallinity impacted on the energy needed to break 
the crystal lattice, the lower the crystallinity, the less energy needed. 
Thus, solid dispersion tends to have a higher solubility [16]. Moreover, 
the grinding process also played a role in changing the crystal lattice 
of famotidine caused by mechanical energy coming from ball collision 
in ball mill apparatus altered the crystal peak interferences [19]. This 
result was in accordance with the solubility test. There was a decrease 
of famotidine melting point in solid dispersion F2. The decline of 
melting point was anticipated as the result of diffractogram showed 
the reduction of peak intensity. This result was also contributed to the 
increasing of solubility.
The reduction of particle size was likely due to the grinding process, 
where mechanical energy was applied to break the particle size of 
famotidine. Moreover, the grinding process was likely influence the 
particle size of mannitol, as shown in photograph SEM previously, 
where famotidine was sticked on mannitol. The smaller particle size 
leads to the greater surface area, which impact on the higher solubility 
of famotidine [17]. The dissolution test is in accordance with the 
solubility test result, an increase in solubility and dissolution rate of 
famotidine formed by solid dispersion.
CONCLUSION
Solid dispersion famotidine with mannitol by co-grinding method 
increased both solubility and dissolution rate significantly (p<0.05) 
compared to intact famotidine and its physical mixture.
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